Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid

A. Leclercq, A. Simon, F. Zobairi, F. Toti, L. Kessler, R. Kessler (Strasbourg, Illkirch, France)

Source: International Congress 2014 – Translational studies in COPD
Session: Translational studies in COPD
Session type: Thematic Poster Session
Number: 835
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Leclercq, A. Simon, F. Zobairi, F. Toti, L. Kessler, R. Kessler (Strasbourg, Illkirch, France). Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid. Eur Respir J 2014; 44: Suppl. 58, 835

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014


Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Bronchoalveolar lavage fluid leukotrienes in the pathomechanism of acute inflammatory events in lung transplant recipients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016

Diagnostic value of pneumocystis-PCR in bronchoalveolar lavage in a clinical setting
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015


Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015


Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016


The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013


Utility of bronchoalveolar lavage in vasculitis patients
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014

Effects of infections on lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) after lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Detection of exosomal miRNA in pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014


The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Importance of early bronchoalveolar lavage in immunocompromised patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015


The value of bronchoalveolar lavage in the diagnosis and management of small airway disease
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011



Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014